Publikationen, an denen er mitarbeitet Manuel Barreiro de Acosta (15)

2022

  1. Radon exposure and inflammatory bowel disease in a radon prone area

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 7, pp. 405-409

  2. Usefulness of peripheral blood monocyte count to predict relapse in patients with inflammatory bowel disease: a prospective longitudinal cohort study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 1, pp. 10-15

2021

  1. Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF

    Journal of Molecular Medicine, Vol. 99, Núm. 9, pp. 1251-1264

2020

  1. Pouchitis: Treatment dilemmas at different stages of the disease

    United European Gastroenterology Journal, Vol. 8, Núm. 3, pp. 256-262

2019

  1. Reply to: Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients

    Journal of Clinical Gastroenterology

2018

  1. Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients under Maintenance with Anti-TNF Therapy

    Journal of Clinical Gastroenterology, Vol. 52, Núm. 3, pp. 229-234

2016

  1. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): A longitudinal cohort study

    Journal of Crohn's and Colitis, Vol. 10, Núm. 1, pp. 13-19

2014

  1. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease

    Inflammatory Bowel Diseases, Vol. 20, Núm. 1, pp. 92-102

2012

  1. Complementary and alternative medicine in inflammatory bowel disease patients: Frequency and risk factors

    Digestive and Liver Disease, Vol. 44, Núm. 11, pp. 904-908

  2. Influence of alexithymia on health-related quality of life in inflammatory bowel disease: Are there any related factors?

    Scandinavian Journal of Gastroenterology, Vol. 47, Núm. 4, pp. 445-453

2011

  1. Emigration to western industrialized countries: A risk factor for developing inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 5, Núm. 6, pp. 566-569

2009

  1. Adalimumab in ulcerative colitis: Two cases of mucosal healing and clinical response at two years

    World Journal of Gastroenterology, Vol. 15, Núm. 30, pp. 3814-3816

  2. Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis

    Journal of Crohn's and Colitis, Vol. 3, Núm. 4, pp. 271-276

2007

  1. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations

    European Journal of Gastroenterology and Hepatology, Vol. 19, Núm. 1, pp. 73-78

2006

  1. Absence of Mycobacterium avium subspecies paratuberculosis in Crohn's disease patients [3]

    Inflammatory Bowel Diseases